Skip to main content
$60.13 -$3.87 (-6.0%)

03:21 PM EDT on 05/13/21

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

CAPS Rating: 4 out of 5

Current Price $60.13 Mkt Cap $4.4B
Open $64.77 P/E Ratio 0.00
Prev. Close $64.00 Div. (Yield) $0.00 (0.0%)
Daily Range $58.52 - $66.89 Volume 1,211,407
52-Wk Range $15.02 - $92.00 Avg. Daily Vol. 1,310,893

Caps

How do you think NASDAQ:NTLA will perform against the market?

Add Stock to CAPS Watchlist

All Players

117 Outperform
4 Underperform
 

All-Star Players

31 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NTLA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

OceanJackson (< 20)
Submitted May 10, 2016

While the CRISPR patent dispute is happening, the hype will drive this one higher within the next couple months.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NTLA VS S&P 500 (SPY)

NASDAQ:NTLA Summary

Fools bullish on NASDAQ:NTLA are also bullish on:

Fools bearish on NASDAQ:NTLA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NTLA.

Recs

0
Member Avatar TMFjbonefish (49.39) Submitted: 5/5/2021 5:06:08 PM : Outperform Start Price: $72.96 NASDAQ:NTLA Score: -16.41

It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is important. Even if the company eventually delivers a treatment or treatments that lead to commercial success, that won't happen for a least a few years. For investors, therefore, owning Intellia stock requires a leap of faith.

Recs

0
Member Avatar CBK (28.85) Submitted: 4/23/2021 8:55:49 AM : Outperform Start Price: $70.36 NASDAQ:NTLA Score: -14.07

Finishing Walter Isaacson's The Code Breaker has made me believe that the next revolution that we are living in is the genomic revolution. Companies like Illumina, Editas, Crispr, Moderna, and Intellia are powering this revolution.

Recs

0
Member Avatar 1russianguy (91.70) Submitted: 2/23/2021 1:01:03 PM : Outperform Start Price: $69.21 NASDAQ:NTLA Score: -18.68

best of us investors, best growth potential for next 3 years

Leaderboard

Find the members with the highest scoring picks in NTLA.

Score Leader

birdup

birdup (< 20) Score: +439.33

The Score Leader is the player with the highest score across all their picks in NTLA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
birdup < 20 3/16/2020 Outperform 5Y $9.87 +510.04% +70.72% +439.33 0 Comment
Playa14 < 20 10/17/2019 Outperform 5Y $11.40 +428.17% +37.69% +390.48 0 Comment
allforone 90.28 3/12/2020 Outperform 5Y $11.22 +436.88% +60.03% +376.85 0 Comment
TraderEnvy < 20 10/4/2019 Outperform 5Y $11.94 +404.28% +41.23% +363.05 0 Comment
clangmead 46.50 12/28/2018 Outperform 5Y $12.51 +381.30% +65.48% +315.83 0 Comment
Kevinkress 63.50 5/4/2020 Outperform 5Y $13.09 +359.98% +46.56% +313.42 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ldigout 95.19 4/13/2020 Outperform 5Y $13.05 +361.39% +48.33% +313.06 0 Comment
CMFMLove 65.50 6/13/2017 Outperform 5Y $12.67 +375.23% +68.62% +306.60 1 Comment
ZabasJ 59.23 4/21/2020 Outperform 5Y $13.33 +351.69% +49.89% +301.79 0 Comment
3dw4rdN1gm4 71.69 2/5/2020 Outperform 5Y $14.20 +324.02% +24.23% +299.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NTLA.